The future of vaccine administration my change forever with Pharmajet's needle-free injector

FDA Approves AFLURIA Flu Vaccine To Be Administered With Pharmajet’s Needle-Free Injector

The future of vaccine administration my change forever with Pharmajet’s needle-free injector The FDA has approved the first needle-free drug system for the delivery of bioCSL’s influenza vaccine AFLURIA. Now, doctors and other health care workers can chose whether they want to administer the influenza vaccine via a needle or through PharmaJet’s needle-free system. Ron Lowy, the CEO of PharmaJet, …

FDA Approves Use of AFLURIA® Influenza Vaccine with PharmaJet’s Needle-Free Injector

August 19th, 2014 PharmaJet® Inc., the developer of a needle-free injection technology to administer medications and vaccines to patients, and bioCSL Inc., the maker of AFLURIA® (Influenza Vaccine) today announced the U.S. Food and Drug Administration (FDA) has approved the PharmaJet Stratis® 0.5mL Needle-Free Jet Injector for delivery of AFLURIA in individuals aged 18 to 64 years. This is the first needle-free delivery …

bioCSL Inc. Launches AFLURIA Shipping Campaign for 2014-2015 Seasonal Influenza

August 5th, 2014 bioCSL Inc. to supply U.S. Market with 16.5 Million Doses Historical reliability, coupled with dedicated commercial and production efforts, drive strong customer prebook order demand Early season deliveries will support U.S. providers’ 2014-15 vaccination needs bioCSL Inc. announced today it has commenced shipping its seasonal influenza vaccine AFLURIA(Influenza Vaccine) for the 2014-2015 flu season. U.S. providers who ordered AFLURIA may …